Evidence map›Paper›PMID 27738906›Full record

ArticleJournal of endocrinological investigation2017

Subclinical hypothyroidism and diabetic nephropathy in Iranian patients with type 2 diabetes.

N Mansournia, S Riyahi, S Tofangchiha, M A Mansournia, M Riahi, Z Heidari, E Hazrati

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of endocrinological investigation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

N MansourniaDepartment of Endocrinology and Metabolism, AJA University of Medical Sciences, P.O.BOX: 141171-8541, Tehran, Iran.
S RiyahiDepartment of Endocrinology and Metabolism, AJA University of Medical Sciences, P.O.BOX: 141171-8541, Tehran, Iran. mohamad.riaahi@yahoo.com.
S TofangchihaDepartment of Internal Medicine, AJA University of Medical Sciences, Tehran, Iran.
M A MansourniaDepartment of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
M RiahiSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Z HeidariDepartment of Endocrinology and Metabolism, Zahedan University of Medical Sciences, Zahedan, Iran.
E HazratiDepartment of Anesthesiology, AJA University of Medical Sciences, Tehran, Iran.
Aja University of Medical Sciences · IRTehran University of Medical Sciences · IRZahedan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAssociation of subclinical hypothyroidism with type 2 diabetes and its complications has been previously documented. These reports were, however, inconclusive and mainly gathered from Chinese and East Asian populations. In this study, we aimed to determine the prevalence of subclinical hypothyroidism and its relationship with diabetic nephropathy in Iranian individuals with type 2 diabetes, drawn from a white Middle Eastern population with an increasing prevalence of diabetes.

methodsIn this cross-sectional study, 255 Iranian participants with type 2 diabetes and without history of thyroid disorders were included. Patients with TSH > 4.2 mIU/L and normal T4 were classified as having subclinical hypothyroidism. Diabetic nephropathy was diagnosed based on abnormal 24-h urinary albumin or protein measurements (24-h urinary albumin ≥30 mg/day or 24-h urinary protein ≥150 mg/day). Multivariate logistic regression was employed to obtain the OR for the relationship between subclinical hypothyroidism and diabetic nephropathy.

resultsWe found that subclinical hypothyroidism and diabetic nephropathy were as prevalent as 18.1 and 41.2 %, respectively, among the participants. We also found that subclinical hypothyroidism was independently associated with higher rates of diabetic nephropathy, after multivariable adjustment (OR [95 % CI] 3.23 [1.42-7.37], p = 0.005).

conclusionsWe found that the prevalence of subclinical hypothyroidism in Iranian diabetic population was among the highest rates reported to date. Our data supported the independent association of subclinical hypothyroidism with diabetic nephropathy, calling for further investigations to evaluate their longitudinal associations.

Indexed as

Cross-Sectional StudiesDiabetes Mellitus, Type 2Diabetic NephropathiesFemaleHumansHypothyroidismIranMaleMiddle AgedPrevalenceThyrotropinThyroxineThyrotropinThyroxineDiabetic nephropathyMicrovascular complicationMiddle EastSubclinical hypothyroidismType 2 diabetes

Identifiers

PMID27738906
OpenAlexW2531797300

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.